Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 276 | 272 | 251 | 273 | 279 |
| Accounts receivable | 9,343 | -4,588 | 4,448 | -2,161 | 3,226 |
| Accounts payable and accrued liabilities | 8,050 | -27,998 | 984 | 12,754 | 169 |
| Other Working Capital | -9,734 | -2,075 | 6,450 | 9,011 | 4,184 |
| Other Operating Activity | -31,163 | -36,894 | -45,473 | -53,155 | -41,372 |
| Operating Cash Flow | $-23,228 | $-71,283 | $-33,340 | $-33,278 | $-33,514 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | 8 | -19 | -44 | -93 |
| Net Acquisitions | N/A | 40 | 22 | 18 | 0 |
| Purchase Of Investment | N/A | N/A | N/A | -6 | N/A |
| Other Investing Activity | -12,655 | 3,232 | 184 | 1,114 | 649 |
| Investing Cash Flow | $-12,742 | $3,280 | $187 | $1,082 | $556 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40,762 | -5,735 | -6,913 | -6,123 | -2,242 |
| Common Stock Issued | 0 | N/A | N/A | N/A | -132 |
| Other Financing Activity | 1,212 | 609,196 | -1,854 | -1,714 | -3,452 |
| Financing Cash Flow | $-39,550 | $603,461 | $-8,767 | $-7,837 | $-5,826 |
| Exchange Rate Effect | -1,311 | -7,155 | -1,173 | -612 | 2,553 |
| Beginning Cash Position | 589,703 | 60,946 | 103,576 | 144,221 | 180,451 |
| End Cash Position | 516,685 | 589,703 | 60,946 | 103,576 | 144,221 |
| Net Cash Flow | $-71,707 | $535,912 | $-41,457 | $-40,033 | $-38,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,228 | -71,283 | -33,340 | -33,278 | -33,514 |
| Capital Expenditure | -87 | N/A | -19 | -44 | -93 |
| Free Cash Flow | -23,315 | -71,283 | -33,359 | -33,322 | -33,607 |